The inaugural recipient of a Neuralink brain implant is recuperating well, as reported by Elon Musk, the billionaire founder of the brain-chip startup.
Musk shared on the X platform that early findings indicate promising detection of neuron spikes, representing the activity of cells using electrical and chemical signals in the brain and body.
Having received FDA clearance last year, Neuralink marked a significant milestone in its quest to assist patients with paralysis and neurological conditions.
The startup’s human trial utilizes a robot for precise placement of a brain-computer interface (BCI) implant, aiming initially to enable control of a computer through thoughts.
Neuralink’s “ultra-fine” threads aid signal transmission in participants’ brains.
Musk mentioned that the first product from Neuralink would be called Telepathy.
The PRIME Study evaluates the safety of Neuralink’s wireless brain-computer interface, employing a surgical robot.
The company faced fines for violating DOT rules, and lawmakers sought an SEC investigation into potential investor misinformation after reported issues with monkey implants.
Musk asserted that no monkeys had died due to Neuralink implants, emphasizing the choice of “terminal” monkeys to minimize risks.
